English

高级检索

标识符 资源中文名称 资源英文名称 疾病概述 制作方法 相关文章
CSTR:16397.09.0F01000513 人CYP2C19转基因小鼠 Balb/c-TgN(CMV-h-CYP2C19)ZLFILAS

药物代谢相关

CSTR:16397.09.0H01000512 scn2b沉默小鼠 C57BL/6J--TgN(pGFP-V-RS-m-Scn2b-shRNA455/456)-ILAS

神经相关疾病

转基因小鼠

CSTR:16397.09.0H01000511 小鼠scn2b转基因小鼠 C57BL/6J--TgN(pcDNA3.1 (-)-m-Scn2b)-ILAS

神经相关疾病

转基因小鼠

CSTR:16397.09.0F01000509 小鼠TGFβ2转基因小鼠 C57BL/6J--TgN(pcDNA3.1 (-)-m- TGFβ2 )-ILAS

代谢相关疾病

转基因小鼠

CSTR:16397.09.0F01000508 人TGFβ1转基因小鼠 C57BL/6J--TgN(pCDNA3.1 (+)-h- TGFβ1)-ILAS

信号转导相关

转基因小鼠

CSTR:16397.09.0A01000507 Fkbp11敲除小鼠 B6;129S5-Fkbp11tm1

骨代谢相关疾病

基因敲除

CSTR:16397.09.0L01000506 ATG5基因敲除小鼠 B6;129-Atg5tm1

自噬相关疾病

基因敲除

CSTR:16397.09.0H01000505 Parp1敲除小鼠 129S-Parp1tm1

皮肤病

基因敲除

CSTR:16397.09.0G01000504 Gadd45a敲除小鼠 B6;129-Gadd45atm1

自身免疫疾病

基因敲除

CSTR:16397.09.0F01000503 全身性表达胰岛素样生长因子 IGF1 沉默转基因小鼠 C57BL/6J--TgN(CMV-EmGFP-siRNA –IGF1)-ILAS

代谢相关疾病

1.ClemmonsDR, MosesAC, MckayMJ , et al. The combination of insulin-like growth factor 1 and insulin-like growth factor binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity. J Clin Endocrinol Metab  2000; 85: 1518 2.MathonnetM , Comte I, L alloue F, et al. insulin-like growth factor 1 induce survival axotomixeed olfactory neurons in the chick. NeurosciLet t 2001; 308 (2) :667

CSTR:16397.09.0F01000502 全身性表达胰岛素样生长因子 IGF1 转基因小鼠 C57BL/6J--TgN(pCDNA3.1 (+)-h-IGF1)-ILAS

代谢相关疾病

1.Bulter AA , M inireview LD, Tissue-specific versus generalized generalized gene tergeting of the Igf1 and Igf1-r genes and their roles in insulin-like growth factor physiology. Endocrinology 2001; 142 (5) : 1686 2.N ixon AJ , Brower-Toland BD, SandellLJ. Primary nucleotide structure of predominant and alternate splice forms of equine insulin-like growth factor 1 and thei rgene expression pat terns in tissue. Am J V et Res 1999;60: 1234

CSTR:16397.09.0G01000501 叉头基因FOXP3敲除小鼠 C.Cg-foxp3tm2

X连锁的淋巴细胞增殖性疾病

 敲除小鼠

ChenZ; Herman AE; Matos M; Mathis D; Benoist C. 2005. Where CD4+CD25+T reg cells impinge on autoimmune diabetes. J Exp Med 202(10): 1387-97.